MAP

 GFR

                 RCP                RAP
Phase SHRNNa SHRHNa SHRNNa SHRHNa SHRNNa SHRHNa SHRNNa SHRHNa
1 139.2 ± 4.8 155.0 ± 5.6 3.5 ± 1.3 3.5 ± 1.1 206.1 ± 20.9 269.8 ± 14.9 141.6 ± 7.3 156.8 ± 4.3
2 137.4 ± 5.5 154.4 ± 5.9 1.2 ± 0.5 1.2 ± 0.3 185.2 ± 14.9 191.0 ± 14.8*   138.8 ± 8.7 153.6 ± 5.5
3 136.0 ± 5.1 149.8 ± 5.3      2.0 ± 0.5      1.4 ± 0.3 208.6 ± 11.4    223.2 ± 18.7    135.6 ± 10.2   149.0 ± 6.1
Table 3: GFR (ml/kg/min), MAP (mmHg), RAP (mmHg) and RCP (BPU/min) in SHRNNa and SHRHNa rats in control (saline) phase1, phase2 (PE) and phase3 (PE in presence of CEC). Values are mean � S.E.M *indicate p<0.05 between control and agonist PE
Goto home»